FDA Investigator LCDR Anastasia M Piliafas Brown
LCDR Anastasia M Piliafas Brown has conducted inspections on 60 sites in 1 countries as of 03 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
60
Last Inspection Date:
03 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with LCDR Anastasia M Piliafas Brown:
Alanna L Mussawwir Bias,
Amanda B Athey,
Amy N Chen,
Amy S Graf,
Andrew H Paeng,
Andrew J Garufi,
Andrew O Ejiofor,
Angela J Alexander,
Art O Czabaniuk,
Ashley L Reiber,
Ashley M Whitehurst,
Azza Talaat,
Barbara A Burke,
Barbara A Gullick,
Barbara A Rusin,
Barbara J Holladay,
Benjamin J Smith,
Bleta Vuniqi,
Brandon L Mariner,
Brian P Putz,
Brittany M Lowe,
Brooke K Higgins,
Brooke K Seeman,
Byungja E Marciante,
Calvin K Cook,
Carole L Jones,
Caroline H Le,
Catherine V Quinlan,
Chaltu Nwakijra,
Charles D Boison,
Charles E Idjagboro,
Charles M Kerns, BLT DO,
Charles M Spyr,
Christine W Twohy,
Clarice J Ahn,
Colleen F Hoyt,
Corrine M Carter,
Crystal M Young Lewis,
Cynthia A Harris, MD, RN,
Cynthia L Aycock,
Cynthia Li,
David J Gasparovich,
Deanna L Lampley,
Debara R Reese,
Diane T Bargo,
Diane T O'brien,
Edmund F Mrak, Jr,
Edward P Potter,
Edwin Melendez,
Emest F Bizjak,
Emily J Orban,
Eric S Pittman,
Erin L Mcfiren,
Erma Zaimova,
Frederick F Razzaghi,
Gail L Katz,
Gary Durbiel Goldner,
George G Calafactor,
Gerald D Bromley, Jr,
Gregory A Cronce,
James E Szelc,
James T Mccoy,
James W Leonette,
Jeanne D Shaffer,
Jennifer A Kemp,
John Dan,
Jonathan W Chapman,
Joseph R Strelnik,
Joseph W Matthews,
Judith A Jankowski,
Juliane C Lessard,
Justin H Price,
Keith M Reilly,
Kennita Riddick,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Krista N Flores,
L'oreal F Walker,
La Tasham Gunter,
Larry K Austin,
Laureen F Kononen,
Laureen M Geniusz,
Lauren E Burke,
Lauren E Sexton,
Laurissa S Flowers,
Linda S Mattingly,
Lori S Lawless,
LT Danielle S Mills,
LT Luis O Rodriguez,
LTJG Aaron B Otis,
Marcellinus D Dordunoo,
Margaret Torres Vazquez,
Marion W Nadeau,
Matthew J Gretkierewicz,
Matthew M Henciak,
Melissa J Garcia,
Merideth K Rose,
Michael K Larson,
Michele L Forster, PhD,
Mikhail V Ovanesov, PhD,
Mildred L Mccray,
Monica J Wilkins,
Monique Rac Lester,
Myra K Casey,
Nancy L Meade,
Neali H Lucas,
Nerizza B Guerin,
Nora S Orrell,
Norman Wong,
Paige E Shelborne,
Patricia A Morrow,
Patrick B Cummings,
Patsy J Domingo,
Paula J Bretz,
Rachel C Harrington,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Reginald Walker,
Robert J Doyle,
Ronald J Kozara,
Ronald T Nowalk,
Ryan J Benedict,
Sanket N Patel,
Sargum C Sood,
Sharon K Thoma, PharmD,
Sherri J Jackson,
Sherry L Secrist, BLT DO,
Shirshendu K Deb, PhD,
Shusheen A Alexander,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven J Thurber,
Steven P Donald,
Susan M North,
Suyang Qin,
Suzanne M Healy,
Suzanne M Muchene,
Tajah L Blackburn,
Tamika E Allen, RN,
Teresa L Fox,
Thomas A Peter,
Tracey L Siebesma,
Twana R Chandler,
Vipulchandra N Dholakia,
Wanda Y Fields,
Wanda Y Honeyblue,
William D Tingley,
William G Nelson,
William J Leonard
LCDR Anastasia M Piliafas Brown's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2004 | FDA 483 | Hildenbrand International, Inc. DBA Osteo Concepts - Form 483, 2004-12-02 |
June, 2006 | FDA 483 | Medtest Holdings, Inc. - Form 483, 2006-06-16 |
November, 2004 | EIR | Aerosol & Liquid Packaging, Inc. - EIR, 2004-11-15 |
November, 2004 | FDA 483 | Aerosol & Liquid Packaging, Inc. - Form 483, 2004-11-15 |
August, 2008 | FDA 483 | Terumo Cardiovascular Systems Corporation - Form 483, 2008-08-12 |
March, 2007 | FDA 483 | Roche Diagnostics Operations, Inc. - Form 483, 2007-03-09 |
February, 2008 | FDA 483 | Lynn Medical Instrument Co. - Form 483, 2008-02-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more